Search keyWord :

Veeva Vault CRM Suite to Unlock Greater Customer Centricity with Launch of Service Center

Expanded suite to unify sales,marketing,medical and service through a connected software and data foundation

Sep 4, 2024 REGULATION

The 9th Anniversary Gala of 17sing came to perfect end - Music is everywhere

TAIPEI,Sept. 4,2024-- In summer time,17sing,Taiwan\'s most popular karaoke social app,celebrates its ninth anniversary and has launched an anniversary event that lasts for more than a month. Tens of m

Sep 4, 2024 BLOCKCHAIN

Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma

SAN FRANCISCOand SUZHOU,China,Sept. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

Sep 4, 2024 MARKET

Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan

BEVERLY,Mass.,Sept. 4,2024-- Axcelis Technologies,Inc. (NASDAQ: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,will be a top-level Platinum Sponsor at

Sep 4, 2024 CRYPTOCURRENCY

CNOOC Limited Brings On-stream Wushi 17-2 Oilfields

HONG KONG,Sept. 4,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces today that Wushi 17-2 Oilfields Development Project has commen

Sep 4, 2024 REGULATION

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

MELBOURNE,Australia,Sept. 4,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces that the Company\'s IPAX-1 Phase I study has been published in Neuro-Oncology Advances,co

Sep 4, 2024 CYBERSECURITY

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases

Through Pfizer Ignite,Acepodia will gain access to Pfizer\'s resources,scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases

Sep 4, 2024 CRYPTOCURRENCY

Nature's Miracle Announces Participation in the H.C. Wainwright Annual Global Investment Conference

ONTARIO,Calif.,Sept. 4,2024-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,today

Sep 4, 2024 CYBERSECURITY

Goodnotes Tours 50 American Colleges to Introduce Students to AI-Enhanced Note-taking & Learning

With AI tools proliferating campuses,Goodnotes will showcase how its AI-powered digital paper can enhance—rather than supplant—student studying,learning,and thinking

Sep 4, 2024 REGULATION

AV-Comparatives Identifies Key Cybersecurity Threats for Summer 2024: Fakeshops, Phishing Attacks and Targeting Children

Unveiling the Rise of Counterfeit Retail Platforms,SophisticatedPhishing Schemes,and Increasing Cyber Risks for Minors in Summer 2024

Sep 4, 2024 BLOCKCHAIN